Novel Use of Extracorporeal Blood Purification for Treatment of Severe, Refractory Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy – A Case Report
This case reports on a 53-year-old male patient with primary refractory high-grade B-cell lymphoma, who was hospitalized to undergo Chimeric Antigen Receptor (CAR) T-cell therapy.